Abbvie Inc. vs Solventum Corporation
ABBV vs SOLV — side-by-side comparison from reported financials. ABBV leads 5, SOLV leads 5 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Solventum Corporation
SOLV · Healthcare
$87.88+1.70%Strained
| Metric | ABBV | SOLV |
|---|---|---|
| Price | $276.43 | $87.88 |
| Market cap | $488B | $15.0B |
| Revenue (TTM) | $64.4B | $8.31B |
| Revenue growth | +1.8% | +0.8% |
| Net margin | 9.8% | 17.3% |
| Free cash flow | $18.2B | -$118M |
| Net cash (debt) | ($56.2B) | ($4.16B) |
| 1-year price return | +19.8% | +22.4% |
| P/E | 77.4 | 10.4 |
| P/E vs own history (cheap-side %) | 23% | 66% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 29% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 6 of 11 |
| Employees | 57,000 | 20,000 |
Full résumé-style profiles: ABBV CV · SOLV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.